Financials
- Market Capitalization 9.73 B
- Employee 673
- Founded 1997
- CEO Robert I. BlumRobert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-11.78
売上高対価格比率
0.16
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 919 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 77.94 USD | -0.18% | -2.34% | +5.48% | +96.59% | 9.91 B USD | ||
| 930 | KYMR Kymera Therapeutics, Inc. - Common Stock | 117.69 USD | -0.39% | -1.97% | +14.52% | +99.14% | 9.79 B USD | ||
| 947 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 343.09 USD | -0.48% | -6.88% | +14.01% | +660.73% | 9.58 B USD | ||
| 956 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.83 USD | +0.35% | -5.39% | +6.65% | +92.77% | 9.37 B USD |